Address: 16th Floor, Plaza VADS, No.1, Jalan Tun Mohd. Fuad,
Taman Tun Dr. Ismail, 60000 Kuala Lumpur, Malaysia
Tel: 603-7727 6390
Web: http://www.yspsah.com/Home/Home.asp
Since its establishment YSP has grown to become one of the innovative and leading pharmaceutical companies in Malaysia. The Group became more competent and hence, in 2004 it gained successful listing on the Bursa Malaysia Securities Bhd ( Kuala Lumpur Stock Exchange ) and later transferred to the Main Board, which marked a major milestone in history. Today the Group boasts a wide array of pharmaceutical, over-the-counter (OTC), veterinary and aquatic products, with regional offices as well as strategic alliances in Singapore, Vietnam, Philippine, Myanmar, Cambodia, Thailand, Indonesia, Brunei, Laos , as well as Sri Lanka, Africa and countries in Middle East.
In addition, YSP have also diversified into traditional herbal products with Sun Ten Pharmaceutical Co. Ltd, a renowned GMP manufacturer of standardized and concentrated herbal extracts from Taiwan R.O.C.
YSP has expertise and capability in the production of gel, capsule, tablet, suppository, cream, syrup, suspension and powder dosage form. These include therapeutic group of antibiotics, antifungals, antacids, anti-diabetics, anti-platelets, antivirals, injectables and eye drops, in order to satisfy customers’ needs and enhance quality of life.
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
Eurasia Group’s Aditya Bhattacharji discusses the relatively modest scope of Malaysia’s recently-launched ‘MYSalam’ scheme; a healthcare programme which aims to provide coverage to the country’s bottom 40 percent of earners.…
After 61 years of single-party rule, the May 2018 electoral victory of the populist Pakatan Harapan (PH) coalition sent shockwaves through the Malaysian political landscape. This has been keenly felt…
Click here to download the Healthcare & Life Sciences Review Malaysia 2018. After recent elections conducted in May 2018 saw Mahathir Mohamad returning as Prime Minister after 15 years to…
American medtech giant Baxter and pan-Asian healthcare service provider Zuellig Pharma have been collaborating in Malaysia to increase the quality and quantity of care that can be given to patients…
Sherene Azli, CEO of the Malaysia Healthcare Travel Council (MHTC), introduces this unique organization in charge of promoting Malaysia internationally as the ‘Cardiology and Fertility Hub of Asia’ and explains…
Rashidah Ibrahim, executive director of Malaysian Vaccines & Pharmaceuticals (MVP), tells the story of MVP as the sole animal vaccines manufacturer in Malaysia. She also explains how important animal health…
Chuwn Leong Ch’ng, CEO of Thunder Print, presents his company’s strategic role within the Malaysian healthcare industry to provide a high-quality packaging services for all type of health products, from…
Robert Kruit, chief executive for Zuellig Malaysia and Brunei, discusses Zuellig’s plans to expand beyond distribution and diversify its offering in the healthcare sector, and how Zuellig’s investments into digital…
Tan Sri Dato’ Ariffin Yusuf, founder and managing director of Primabumi, explains how he came to build Primabumi in 1975 and how he managed to position the company as a…
Halal pharmaceuticals – medicines that do not contain any alcohol, parts of animals such as dogs, pigs, bees, or any other substances prohibited as ‘haram’ under Shariah law – are…
Lee Yee Keng, head of healthcare sector of KPMG in Malaysia, highlights the opportunities Malaysia can offer to the healthcare industry, including its potential for private-public partnerships, and how the…
See our Cookie Privacy Policy Here
